Literature DB >> 2170249

Use of the pudendo-anal reflex in the treatment of neurogenic faecal incontinence.

N R Binnie1, B M Kawimbe, M Papachrysostomou, A N Smith.   

Abstract

An electrical stimulator has been devised to treat neurogenic faecal incontinence caused by pudendal nerve neuropathy and works on the basis of repeated stimulation of the pudendo-anal reflex arc. Although conduction in the pudendo-anal reflex arc may be prolonged, and is so in neurogenic faecal incontinence, it must be shown to be present before the method can be used. This stimulation results in an immediate rise in the pressure in the anal canal and a significant increase in the electromyographic activity of the external anal sphincter. Maintenance of the stimulus over a two month period raised the mean resting pressure significantly in the anal canal and increased the reflex and voluntary responses of the external anal sphincter to coughing and squeezing actions respectively. The length of the sphincter was not affected. There was widening of the mean motor unit potential duration, though this was not significant. The resting electromyogram was enhanced after the course of treatment, indicating greater spontaneous activity in the external sphincter. The changes led to seven of the eight patients studied becoming continent at the end of the treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2170249      PMCID: PMC1378668          DOI: 10.1136/gut.31.9.1051

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Royal Society of Medicine, Section of Proctology; Meeting 27 November 1974. President's Address. Anorectal incontinence.

Authors:  A G Parks
Journal:  Proc R Soc Med       Date:  1975-11

2.  Bowel program for institutionalized adults.

Authors:  M C Habeeb; M D Kallstrom
Journal:  Am J Nurs       Date:  1976-04       Impact factor: 2.220

3.  The treatment of incontinence by electronic implants. Hunterian Lecture delivered at the Royal College of Surgeons of England on 8th December 1966.

Authors:  K P Caldwell
Journal:  Ann R Coll Surg Engl       Date:  1967-12       Impact factor: 1.891

4.  Bowel management in the neurologically disabled. The patient's viewpoint.

Authors:  J Munn
Journal:  Proc R Soc Med       Date:  1972-01

5.  Anal sphincter responses after perianal electrical stimulation.

Authors:  E Pedersen; B Klemar; H D Schrøder; J Tørring
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

6.  Progress in biofeedback conditioning for fecal incontinence.

Authors:  M A Cerulli; P Nikoomanesh; M M Schuster
Journal:  Gastroenterology       Date:  1979-04       Impact factor: 22.682

7.  Electrical treatment of anal incontinence.

Authors:  B R Hopkinson; R Lightwood
Journal:  Lancet       Date:  1966-02-05       Impact factor: 79.321

8.  Physiological studies of the anal sphincter musculature in faecal incontinence and rectal prolapse.

Authors:  M E Neill; A G Parks; M Swash
Journal:  Br J Surg       Date:  1981-08       Impact factor: 6.939

Review 9.  Progress report. Anal continence.

Authors:  H L Duthie
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

10.  Use of biofeedback in treatment of fecal incontinence in patients with meningomyelocele.

Authors:  A Wald
Journal:  Pediatrics       Date:  1981-07       Impact factor: 7.124

View more
  3 in total

1.  Posterior tibial nerve stimulation for faecal incontinence after partial spinal injury: preliminary report.

Authors:  B B Mentes; O Yüksel; A Aydin; T Tezcaner; A Leventoğlu; B Aytaç
Journal:  Tech Coloproctol       Date:  2007-05-25       Impact factor: 3.781

2.  A regional audit of the investigation and treatment of colorectal and pelvic floor disorders (1984-1991).

Authors:  J S Varma; N R Binnie; B Kawimbe; M Papachrysostomou; A N Smith
Journal:  Int J Colorectal Dis       Date:  1993-07       Impact factor: 2.571

3.  Neurostimulation for neurogenic bowel dysfunction.

Authors:  J Worsøe; M Rasmussen; P Christensen; K Krogh
Journal:  Gastroenterol Res Pract       Date:  2013-03-21       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.